Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ágata Almela
Observed names:
Agata Almela,
Ágata Almela Gallego
Institutions:
Hospital Universitario de León,
Complejo Asistencial Universitario de León
Observed institutions:
Hospital Universitario de León,
Complejo Asistencial Universitario de León
OpenAlex ID:
A5092932741
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study
2025
·
Rebeca Rodríguez-Veiga
, Cristina Gil
, et al.
·
Haematologica
·
3
PDF
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study
2026
·
José Vicente Gil
, Claudia Sargas
, et al.
·
Haematologica
·
2
Incidence of primary plasma cell leukemia with the new diagnostic criteria
2023
·
Virginia Jano
, Irene Padilla
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Upfront venetoclax plus quizartinib with low-dose cytarabine or azacitidine in older unfit patients with acute myeloid leukemia: the phase I/II VEN-A-QUI trial
2026
·
Juan Miguel Bergua
, Pilar Lloret-Madrid
, et al.
·
Journal of Hematology & Oncology
PDF
Real‐World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3 ‐Mutated AML: The PETHRATIFY Study
2026
·
Mónica Alejandra Romero Riquelme
, Gaspar Aspas Requena
, et al.
·
American Journal of Hematology
PDF
POSTER: MDS-790: Risk-Stratified Survival and Treatment Patterns in Myelodysplastic Syndromes: A Nationwide Analysis From the Spanish Group of Myelodysplastic Syndromes (GES MD)
2026
·
Raúl Azibeiro Melchor
, David Valcárcel Ferreiras
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MDS-700: Excess Mortality in Myelodysplastic Neoplasms With Ring Sideroblasts Compared With the Spanish General Population: A GES MD Registry Study
2026
·
Pina Gabriela Gálvez Zavala
, María del Cisne Samaniego Silva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Risk-Stratified Survival and Treatment Patterns in Myelodysplastic Syndromes: A Nationwide Analysis From the Spanish Group of Myelodysplastic Syndromes (GESMD)
2026
·
Raúl Azibeiro Melchor
, David Valcárcel Ferreiras
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Excess Mortality in Myelodysplastic Neoplasms With Ring Sideroblasts Compared With the Spanish General Population: A GESMD Registry Study
2026
·
Pina Gabriela Gálvez Zavala
, María del Cisne Samaniego Silva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group
2026
·
Rafael Colmenares
, Eva Barragán
, et al.
·
Bone Marrow Transplantation
PDF
Identifying patients with indolent Acute Myeloid Leukemia: Long term survivors after best supportive care only, results from the pethema registry
2025
·
Jorge Labrador
, David Martinez-Cuadron
, et al.
·
Blood
Improved outcomes in 17,908 acute myeloid leukemia patients across last three decades: Results from the multinational pethema registry
2025
·
Jorge Labrador
, David Martinez-Cuadron
, et al.
·
Blood
Measurable residual disease (MRD) assessment as an early end point oftreatment efficacy in acute myeloid leukemia (AML): A pethema studyof 2,623 patients (Pts) treated with intensive therapy
2025
·
Bruno Paiva
, Leire Burgos
, et al.
·
Blood
PDF
Daratumumab – VTD vs VTD: peri-transplant evaluation
2023
·
Virginia Jano
, Belen Ballina
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
14
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type